Ligand Pharmaceuticals | LGND - Trade Creditors


Ligand Pharmaceuticals reported $3.24M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Agenus USD 82.99M 2.3M Dec/2025
Amgen USD 20.89B 1.25B Dec/2025
Anika Therapeutics USD 6.04M 1.31M Dec/2025
Arrowhead Research USD 32.94M 15.26M Dec/2025
Baxter International USD 999M 46M Dec/2025
Bristol-Myers Squibb USD 4.29B 1.14B Sep/2025
Eli Lilly USD 5.38B 1.12B Dec/2025
Enanta Pharmaceuticals USD 1.88M 63K Dec/2025
Enviri Corporation USD 239.65M 10.99M Dec/2025
Gilead Sciences USD 715M 93M Dec/2025
GlaxoSmithKline GBP 15.38B 294M Dec/2025
Glaxosmithkline GBP 20.72B 346.14M Dec/2025
Heron Therapeutics USD 8.99M 3.02M Dec/2025
Insmed USD 79.91M 316K Dec/2025
Intrexon USD 4.85M 3.12M Jun/2024
Ionis Pharmaceuticals USD 14.33M 8.47M Sep/2025
Karyopharm Therapeutics USD 4M 1.39M Dec/2025
Ligand Pharmaceuticals USD 3.24M 24.52M Dec/2025
MacroGenics USD 4.79M 1.15M Dec/2025
Merck USD 4.15B 102M Sep/2025
Pacira USD 15.15M 2.54M Dec/2025
Pfizer USD 5.02B 142M Sep/2025
Rigel Pharmaceuticals USD 3.85M 3.44M Sep/2025
Sangamo BioSciences USD 10.74M 7.46M Jun/2025
Veracyte USD 4.59M 916K Dec/2025